Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review

References

• World Health Organization. Worldwide country situation analysis: response to antimicrobial resistance. Geneva: WHO 2015.
   Google Scholar
• Centers for Disease Control and Prevention (US). National strategy for combating antibiotic resistant bacteria: US Government; 2014 [cited 2015 May 5]. Available from: http://www.cdc.gov/Drugresistance/Pdf/Carb_National_Strategy.Pdf.
   Google Scholar
• Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis. 2009;49:271–274.
   PubMed Web of Science ®Google Scholar
• Al-Hasan MN, Razonable RR, Eckel-Passow JE, et al. Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant. 2009;9:835–843.
   PubMed Web of Science ®Google Scholar
• Kalpoe JS, Sonnenberg E, Factor SH, et al. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2012;18:468–474.
   PubMed Web of Science ®Google Scholar
• Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis. 2012;14:198–205.
   PubMed Web of Science ®Google Scholar
• Schmidt-Hieber M, Blau I, Schwartz S, et al. Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients. Int J Hematol. 2007;86:158–162.
   PubMed Web of Science ®Google Scholar
• Pinheiro HS, Mituiassu AM, Carminatti M, et al. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients. Transplant Proc. 2010;42:486–487.
   PubMed Web of Science ®Google Scholar
• Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42:5–12.
   PubMed Web of Science ®Google Scholar
• Kantele A, Lääveri T, Mero S, et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60:837–846.
   PubMed Web of Science ®Google Scholar
• Lübbert C, Straube L, Stein C, et al. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol. 2015;305:148–156.
   PubMed Web of Science ®Google Scholar
• Kamada N, Chen GY, Inohara N, et al. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14:685–690.
   PubMed Web of Science ®Google Scholar
• Gosalbes MJ, Vázquez-Castellanos JF, Angebault C, et al. Carriage of Enterobacteria producing extended-spectrum β-lactamases and composition of the gut microbiota in an Amerindian community. Antimicrob Agents Chemother. 2016;60:507–514.
   Web of Science ®Google Scholar
• Ubeda C, Bucci V, Caballero S, et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun. 2013;81:965–973.
   PubMed Web of Science ®Google Scholar
• Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13:790–801.
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–415.
   PubMed Web of Science ®Google Scholar
• Youngster I, GH R, Pindar C, et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312:1772–1778.
   PubMed Web of Science ®Google Scholar
• Emanuelsson F, Claesson BEB, Ljungstrom L, et al. Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients. Scand J Infect Dis. 2014;46:89–97.
   PubMed Web of Science ®Google Scholar
• Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002.
   PubMed Web of Science ®Google Scholar
• Dhere T. A pilot study examining the safety and efficacy of early fecal transplant in patients infected with Clostridium difficile at high risk of relapse [Internet]. NCT02465463; 2015 [cited 2015 Nov 16]. Available from: https://clinicaltrials.gov/ct2/show/NCT02465463.
   Google Scholar
• Patel R, Allen SL, Manahan JM, et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl. 2001;7:27–31.
   PubMed Web of Science ®Google Scholar
• Arnow PM, Carandang GC, Zabner R, et al. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis. 1996;22:997–1003.
   PubMed Web of Science ®Google Scholar
• Bion JF, Badger I, Crosby HA, et al. Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med. 1994;22:40–49.
   PubMed Web of Science ®Google Scholar
• van Saene HK, Stoutenbeek CP, Gilbertson AA. Review of available trials of selective decontamination of the digestive tract (SDD). Infection. 1990;18:S5–S9.
   PubMedGoogle Scholar
• Saidel-Odes L, Polachek H, Peled N, et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol. 2012;33:14–19.
   PubMed Web of Science ®Google Scholar
• Katchman E, Marquez M, Bazerbachi F, et al. A comparative study of the use of selective digestive decontamination prophylaxis in living-donor liver transplant recipients. Transpl Infect Dis. 2014;16:539–547.
   PubMed Web of Science ®Google Scholar
• Cheng VC, Chen JH, Tai JW, et al. Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature. BMC Infect Dis. 2014;14:514.
   PubMed Web of Science ®Google Scholar
• Halaby T, al Naiemi N, Kluytmans J, et al. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother. 2013;57:3224–3229.
   PubMed Web of Science ®Google Scholar
• Huttner B, Haustein T, Uçkay I, et al. Decolonization of intestinal carriage of extended-spectrum B-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother. 2013;68:2375–2382.
   PubMed Web of Science ®Google Scholar
• Oren I, Sprecher H, Finkelstein R, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infect Control. 2013;41:1167–1172.
   PubMed Web of Science ®Google Scholar
• Singh R, van Nood E, Nieuwdorp M, et al. Donor feces infusion for eradication of extended spectrum beta-lactamase producing Escherichia coli in a patient with end stage renal disease. Clin Microbiol Infect. 2014;20:O977–O978.
   PubMed Web of Science ®Google Scholar
• Freedman A, Eppes S. Use of stool transplant to clear fecal colonization with carbapenem-resistant Enterobacteriaceae (CRE): proof of concept. IDWeek Conference. Philadelphia: Infectious Disease Society of America; 2014.
   Google Scholar
• Wei Y, Gong J, Zhu W, et al. Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis. BMC Infect Dis. 2015;15:265.
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF, Sullivan E, Ballon-Landa G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J Clin Microbiol. 2015;53:1986–1989.
   PubMed Web of Science ®Google Scholar
• Stripling J, Kumar R, Baddley JW, et al. Loss of vancomycin-resistant Enterococcus fecal dominance in an organ transplant patient with Clostridium difficile colitis after fecal microbiota transplant. Open Forum Infect Dis. 2015;2:ofv078.
   PubMed Web of Science ®Google Scholar
• Dubberke E, Jones C. Clearance of vancomycin-resistant Enterococcus concomitant with administration of a microbiota-based drug targeted at recurrent Clostridium difficile infection. Copenhagen: European Congress of Clinical Microbiology and Infectious Diseases; 2015.
   Google Scholar
• Pardi DS, Kelly C, Khanna S, et al. Ser-109, an oral, microbiome-based therapeutic, is efficacious for the treatment of recurrent C. difficile and eliminates Enterobacteriacea and vancomycin-resistant Enterococci colonizing the gut. Interscience Conference on Antimicrobial Agents and Chemotherapy; 2014; Washington, DC.
   Google Scholar
• Lagier J-C, Million M, Fournier P-E, et al. Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae. J Hosp Infect. 2015;90:173–174.
   PubMed Web of Science ®Google Scholar
• Dubberke E. Use of fecal microbiota transplantation (FMT) to reverse multi-drug resistant organism carriage [Internet]. NCT02312986; 2015 [cited 2015 Nov 16]. Available from: https://clinicaltrials.gov/ct2/show/NCT02312986.
   Google Scholar
• Zerr D. Fecal microbiota transplantation as a strategy to eradicate resistant organisms [Internet]. NCT02543866; 2015 [cited 2015 Nov 16]. Available from: https://clinicaltrials.gov/ct2/show/NCT02543866.
   Google Scholar
• Basak GW. Prospective observational study of fecal microbiota transplantation used to eradicate gut-colonizing multidrug-resistant bacteria in patients with blood disorders [Internet]. NCT02461199; 2015 [cited 2015 Nov 16]. Available from: https://clinicaltrials.gov/ct2/show/NCT02461199.
   Google Scholar
• Li N. Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus Aureus enterocolitis [Internet]. NCT02390622; 2013 [cited 2015 Nov 16]. Available from: https://clinicaltrials.gov/ct2/show/NCT02390622.
   Google Scholar
• Harbarth S. A randomized controlled multicenter trial of a five day course of oral colistin and neomycin followed by restoration of the gut microbiota using fecal transplantation to eradicate intestinal carriage of extended spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae in high-risk patients [Internet]. NCT02472600; 2015 [cited 2015 Nov 16]. Available from: https://clinicaltrials.gov/ct2/show/NCT02472600.
   Google Scholar
• de Castro CG, Ganc AJ, Ganc RL, et al. Fecal microbiota transplant after hematopoietic SCT: report of a successful case. Bone Marrow Transplant. 2015;50:145.
   PubMed Web of Science ®Google Scholar
• Neemann K, Eichele DD, Smith PW, et al. Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012;14:E161–E165.
   PubMed Web of Science ®Google Scholar
• Jenq RR, Ubeda C, Taur Y, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012;209:903–911.
   PubMed Web of Science ®Google Scholar
• Vossen JM, Heidt PJ, van den Berg H, et al. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis. 1990;9:14–23.
   PubMed Web of Science ®Google Scholar
• Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013;155:1451–1463.
   PubMed Web of Science ®Google Scholar
• Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009;15:1546–1558.
   PubMed Web of Science ®Google Scholar
• Kapel N, Thomas M, Corcos O, et al. Practical implementation of faecal transplantation. Clin Microbiol Infect. 2014;20:1098–1105.
   PubMed Web of Science ®Google Scholar
• Lagier J-C. Faecal microbiota transplantation: from practice to legislation before considering industrialization. Clin Microbiol Infect. 2014;20:1112–1118.
   PubMed Web of Science ®Google Scholar